Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation

Pediatric Transplantation

Volumn 17, Issue 2, 2013, Pages

  Jung, Young H ^a   Moon, Kyung C ^b   Ha, Jong W ^a   Kim, Sang Joon ^a   Ha, Il Soo ^a   Cheong, Hae I ^a   Kang, Hee G ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

BK virus; graft rejection; kidney transplantation; leflunomide

Indexed keywords

CREATININE; CYCLOSPORIN; IMMUNOGLOBULIN; LEFLUNOMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ARTICLE; BK VIRUS ALLOGRAFT NEPHROPATHY; BK VIRUS INFECTION; CASE REPORT; CHILD; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; DRUG SUBSTITUTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY TRANSPLANTATION; PEDIATRIC SURGERY; RENAL GRAFT DYSFUNCTION; SCHOOL CHILD; SIMIAN VIRUS 40; TREATMENT DURATION; VIRUS LOAD;

ANTIVIRAL AGENTS; BK VIRUS; CHILD; FEMALE; HUMANS; ISOXAZOLES; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; TUMOR VIRUS INFECTIONS;

EID: 84874504830     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12029     Document Type: Article

References (32)

1. Ginevri F, Santis RD, Comoli P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003: 75: 1266-1270. (Pubitemid 36513032)
2. Dall A, Hariharan S,. BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol 2008: 3: S68-S75.
3. Hilton R, Tong CY,. Antiviral therapy for polyomavirus associated nephropathy after renal transplantation. J Antimicrob Chemother 2008: 62: 855-859.
4. Liacini A, Seamone ME, Muruve DA, Tibbles LA,. Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: Toward a new therapy for BK virus infection. Transplantation 2010: 90: 1450-1457.
5. Smith JM, Dharnidharka VR, Talley L, Martz K, McDonald RA,. BK virus nephropathy in pediatric renal transplant recipients: An analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol 2007: 2: 1037-1042.
6. Saad ER, Bresnahan BA, Cohen EP, et al. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation 2008: 85: 850-854. (Pubitemid 351440750)
7. Dheir H, Sahin S, Uyar M, et al. Intensive polyoma virus nephropathy treatment as a preferable approach for graft surveillance. Transplant Proc 2011: 43: 867-870.
8. Teschner S, Gerke P, Geyer M, et al. Leflunomide therapy for polyomavirus-induced allograft nephropathy: Efficient BK virus elimination without increased risk of rejection. Transplant Proc 2009: 41: 2533-2538.
9. Bansal S, Lucia MS, Wiseman A,. A case of polyomavirus-associated nephropathy presenting late after transplantation. Nat Clin Pract Nephrol 2008: 4: 283-287. (Pubitemid 351589732)
10. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008: 8: 753-760. (Pubitemid 351347767)
11. Araya CE, Garin EH, Neiberger RE, Dharnidharka VR,. Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients. Pediatr Transplant 2010: 14: 145-150.
12. Smith JM, Mcdonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP,. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004: 4: 2109-2117. (Pubitemid 39611641)
13. Acott PD, Hirsch HH,. BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol 2007: 22: 1243-1250. (Pubitemid 47054911)
14. Brocker V, Schwarz A, Becker JU,. BK virus nephropathy after kidney transplantation. Pathology 2011: 32: 339-405.
15. Puliyanda DP, Toyoda M, Traum AZ, et al. Outcome of management strategies for BK virus replication in pediatric renal transplant recipients. Pediatr Transplant 2008: 12: 180-186. (Pubitemid 351326915)
16. Weiss AS, Gralla J, Chan L, Klem P, Wiseman AC,. Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: A comparison of two reduction strategies. Clin J Am Soc Nephrol 2008: 3: 1812-1819.
17. Bohl DL, Brennan DC,. BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2007: 1: S36-S46.
18. Pallet N, Burgard M, Quamouss O, et al. Cidofovir may be deleterious in BK virus-associated nephropathy. Transplantation 2010: 89: 1542-1544.
19. Sessa A, Esposito A, Giliberti A, et al. BKV reactivation in renal transplant recipients: Diagnostic and therapeutic strategy-case reports. Transplant Proc 2008: 40: 2055-2058.
20. Izzedine H, Launay-Vacher V, Deray G,. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 2005: 45: 804-817. (Pubitemid 43181039)
21. Farasati NA, Shapiro R, Vats A, Randhawa P,. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005: 79: 116-118. (Pubitemid 40140009)
22. Chon WJ, Josephson MA,. Leflunomide in renal transplantation. Expert Rev Clin Immunol 2011: 7: 273-281.
23. Muller A, Beck B, Theilemann K, et al. Detection of polyoma virus BK and JC in children with kidney disease and renal transplant recipients. Pediatr Infect Dis 2005: 24: 778-781. (Pubitemid 41324885)
24. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005: 5: 582-594. (Pubitemid 40313351)
25. Alexander RT, Langlois V, Tellier R, Robinson L, Hebert D,. The prevalence of BK viremia and urinary viral shedding in a pediatric renal transplant population: A single-center retrospective analysis. Pediatr Transplant 2006: 10: 586-592.
26. Araya CE, Lew JF, Fennell RS, Neiberger RE, Dharnidharka VR,. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy. Pediatr Transplant 2006: 10: 32-37.
27. Araya CE, Lew JF, Fennell RS, Neiberger RE, Dharnidharka VR,. Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy. Pediatr Transplant 2008: 12: 790-795.
28. Comoli P, Azzi A, Maccario R, et al. Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 2004: 78: 1229-1232. (Pubitemid 39426446)
29. Herman J, Ranst VM, Snoeck R, et al. Polyomavirus infection in pediatric renal transplant recipients: Evaluation using a quantitative real-time PCR technique. Pediatr Transplant 2004: 8: 485-492. (Pubitemid 39279019)
30. Hymes LC, Warshaw BL,. Polyomavirus (BK) in pediatric renal transplants: Evaluation of viremic patients with and without BK associated nephritis. Pediatr Transplant 2006: 10: 920-922. (Pubitemid 44683636)
31. Hymes L,. BK virus nephropathy: A pediatric nephrologist's perspective. Transplant Rev (Orlando) 2010: 24: 28-31.
32. Vats A, Shapiro R, Randhawa SP, et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003: 75: 105-112. (Pubitemid 36139705)